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INTRODUCTION
Although age-standardised rates of stroke mortality have
decreased worldwide in the past two decades, the absolute
number of people who have a stroke every year, stroke sur-
vivors, related deaths, and the overall global burden of
stroke (DALYs lost) are great and increasing (Feigin et al.,
2010). Mortality rate of cerebrovascular disease in 2013 in
Latvia was 242.8 per 100 000, which is one of the highest in
Europe (Anonymous, 2015). According to Latvian Stroke
Register data, stroke due to large artery atherosclerosis is
32%.
Most of the studies document beneficial outcomes due to
periprocedual events (stroke, miocard infarction, mortality
rate) after endovascular treatment. However, information
about changes of health-related quality of life (HRQoL) af-
ter revascularisation, as well how revascularisation proce-
dure influences daily activities, cognitive functioning and
general health, is controversial (Abelha et al., 2008; Stalker
et al., 2010; Cohen et al., 2011).
The objectives of our study were to evaluate and describe
the HRQoL among patients with severe carotid artery dis-
ease (carotid stenosis 70%); to evaluate the difference of
HRQoL between symptomatic and asymptomatic carotid ar-
tery disease; and to explore the possible associations be-
tween some demographic and clinical characteristics of pa-
tients with carotid artery disease and HRQoL.
MATERIALS AND METHODS
The cross-sectional study included 33 patients with verified
severe asymptomatic (no previous medical history of tran-
sient ischemic attack (TIA) or stroke) or symptomatic (TIA,
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Information about changes of health-related quality of life (HRQoL) after revascularisation as well
how revascularisation procedure influences daily activities, cognitive functioning and general
health is controversial. The objectives of our study were to evaluate and describe the HRQoL
among patients with severe carotid artery disease; to evaluate the difference of HRQoL between
symptomatic and asymptomatic carotid artery disease; and to explore the possible associations
between some demographic and clinical characteristics of patients with carotid artery disease and
HRQoL. The cross-sectional study included 33 patients who were referred for carotid artery en-
darterectomy. Data assessment was done one to three days before surgery. The HRQoL was as-
sessed using the Medical Outcome Survey Form 36 (SF-36v2). Patients with symptomatic carotid
artery disease had the lowest mean SF-36v2 scores for physical functioning, role-physical, gen-
eral health and mental health. There was moderate correlation (rs= 0.441) between mean SF-
36v2 scores of mental health and Montreal Cognitive Assessment Scale (MoCA) scores. There is
also indirect indication for probable correlation between MoCA test scores and mean SF-36v2
scores of social functioning, which might become statistically significant if more patients would be
included. Patients with severe carotid artery disease in our study had lower mean SF-36v2 scores
for role-physical, for bodily pain and for perception about their health status (general health).
HRQoL in patients with severe carotid artery, stenosis was poorer in patients with symptomatic
carotid artery disease and was not affected by gender and other clinical characteristics.
Key words: carotid stenosis, HRQoL, SF-36v2 Survey Form, MoCA (Montreal Cognitive Assess-
ment) scale.
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minor stroke (modified Rankin Scale 0–III)) carotid artery
disease. Severe carotid artery stenosis  70% was defined
according to North American Symptomatic Carotid Artery
Endarterectomy Trial (NASCET) criteria (Barnett et al.,
1998). The patients were referred for endarterectomy to the
Pauls Stradiòð Clinical University Hospital. Carotid artery
stenosis was estimated with computer tomography angio-
graphy. Patients under 18 years of age, with malignant dis-
ease and major stroke (modified Rankin Scale IV–V), were
excluded.
Data of patients’ gender, age, lifestyle characteristics
(smoking, alcohol consumption, body mass index) and
comorbidities (other atherosclerotic disease, diabetes melli-
tus, atrial fibrillation) were collected.
Patients were defined as smokers if they were current or
former smokers. Body mass index (BMI) was calculated as
weight (kg) divided by the square of height in metres (m2).
Other atherosclerotic disease was defined as coronary artery
and peripheral artery diseases.
Neurological examination was done using the NIHSS (Na-
tional Institutes of Health Stroke Scale). Functional out-
come was assessed using the Barthel Index, which measures
activity of daily living, and for evaluation of the extent of
handicap the modified Rankin Scale (mRS) was used
(Aminoff et al., 2009).
All data assessment was done one to three days before sur-
gery by a neurologist.
Cognitive function was assessed using the Montreal Cogni-
tive Assessment Scale (MoCA). MoCA is a 10-minute cog-
nitive screening tool used to detect mild cognitive impair-
ment. The MoCA scores range from 0 to 30 and are divided
in 8 subscores: visuospatial/executive (5 points), naming (3
points), attention (3 points), calculation (3 points), language
(3 points), abstraction (2 points), memory (5 points), and
orientation (6 points), and an additional point is given to
each patient who has educational experience of 12 years or
less. A final total score of 26 and above is considered nor-
mal (Nasreddine et al. 2005; 2015).
Health-related quality of life (HRQoL) was assessed using
the Medical Outcome Survey Short Form 36 (SF-36v2). Pa-
tients filled the survey form (paper version) in the presence
of an investigator. The SF-36v2 includes one favourably
scored scale measuring each of eight health domains: physi-
cal functioning, role participation with physical health prob-
lems (role-physical), bodily pain, general health, vitality,
social functioning, role participation with emotional health
problems (role-emotional), and mental health (Ware et al.,
2008). SF-36 has been validated in patients with cardiovas-
cular disease, stroke and in the general population (Ware
and Sherbourne, 1992; Failde and Ramos, 2000). For each
item, scores are coded, summed and transformed into a
scale from 0 (worst possible health state measured by the
questionnaire) to 100 (best possible health state) (Ware et
al., 2008). A difference of 5 to 10 points is considered a
clinically important change for an individual subject (a
smaller difference may be important for group comparisons)
(Cohen, 1988). In addition, the SF-36 provides summary
scales for overall physical and mental health, which are
standardised to a population mean of 50 and a standard de-
viation of 10, and for which individual differences of 2.5 to
5 points are considered clinically meaningful (Cohen,
2011). The Latvian and Russian version of the SF-36v2,
cross-culturally validated, was used.
Informed consent was obtained from all patients, and the
study was approved by the Ethics Committee of Rîga
Stradiòð University.
T a b l e 1
CHARACTERISTICS OF PATIENTS WITH SEVERE CAROTID AR-
TERY STENOSIS
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The data were analysed using IBM SPSS v.22. software.
Continuous variables were described as means ± SD, and
categorical variables were presented as counts and percent-
ages. The non-parametric Mann–Whitney test was used to
compare SF-36v2 mean scores in subgroups of patients
such as gender, carotid artery disease, comorbidities. The
non-parametric Spearman’s rank correlation was used to
measure the strength of association between SF-36v2 health
domain scores and variables such as BMI, Barthel Index,
MoCA test scores. All tests were considered statistically
significant at p < 0.05.
RESULTS
Characteristics of patients. Our study included 33 patients
with severe carotid artery stenosis ( 70%) who were trans-
ferred to Pauls Stradiòð Clinical University Hospital for
endarterectomy. The demographic, lifestyle and clinical
characteristics of the patients are presented in Table 1.
There were 16 (48.5%) males and 17 (51.5%) females. Av-
erage age of patients was 68.5 ± 8.7 (44–81). Asymptomatic
carotid artery disease was observed in 18 (54.5%) patients,
and symptomatic (TIA 5 (15.2%) and stroke 10 (30.3%))
carotid artery disease in 15 patients. Most of the patients did
not have any neurological symptoms — 23 (69.7%), nine
patients had NIHSS 6, and only one patient had NIHSS 9.
About half of the patients had a Barthel Index of 20, and
only one patient had a Barthel Index of 12.
Half of the patients — 15 (45.5%) had other atherosclerotic
disease (coronary artery disease, peripheral artery disease),
eight (24.2%) patients had diabetes mellitus, and four had
atrial fibrilation. As many as 39.4% patients were smokers,
57.6% patients consumed alcohol (patients who consumed
more than 12 standard drinks a year were considered as
drinkers), and 34.4% were obese.
One-third of patients — nine (27.3%) and a total MoCA
score  26, and three patients (9.1 %) had a MoCA score of
20–25 points.
Mean SF-36v2 scores according to the demographic and
clinical characteristics of patients with severe carotid ar-
tery disease. Table 2 shows mean SF-36v2 scores in sub-
groups of patients by gender, cerebrovascular accident, and
comorbidities. The lowest mean SF-36v2 scores for physi-
cal functioning were observed in patients with symptomatic
carotid artery disease. For role – physical, the lowest mean
SF-36v2 scores were in patients with symptomatic carotid
artery disease and in patients with comorbidities. For bodily
pain – women, the lowest scores were observed in patients
with symptomatic carotid artery disease and in patients with
comorbidities. For perception about their health status (gen-
eral health), women had the lowest mean SF-36v2 scores.
Although there were no statistically significant differences,
scores for physical functioning and role – physical in pa-
tients with symptomatic carotid artery disease might be sta-
tistically significant if the number of included patients was
larger, as there was a wide SD range.
The non-parametric Spearman’s rank correlation coefficient
(Table 3) was weakly statistically significant between mean
SF-36v2 score of mental health domain and the Barthel In-
dex (rs = 0.383) in patients with severe carotid artery steno-
T a b l e 2
MEAN (SD) SF-36v2 SCORES FOR PATIENTS WITH SEVERE CAROTID ARTERY STENOSIS
PF p RP p BP p GH p VT p SF p RE p MH p












































































































































p value was calculated according to non-parametric Mann-Whitney test; statistically significant difference was considered p < 0.05. PF, physical functioning;
RP, role participation with physical health problems (role-physical); BP, bodily pain; GH, general health; VT, vitality; SF, social functioning; RE, role par-
ticipation with emotional health problems (role-emotional); MH, mental health.
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sis. Moderate correlation (rs = 0.441) was observed between
mean SF-36v2 score of mental health and MoCA score
(Fig. 1). There is also indirect evidence of correlation be-
tween MoCA test score and mean SF-36v2 score of social
functioning, which might become statistically significant if
more patients would be included.
DISCUSSION
In our study, patients with significant carotid artery disease
had lower mean SF-36v2 scores for physical functioning,
role-physical, bodily pain, and general health. The SF-36v2
scores were lower in women than men, in patients with
symptomatic carotid artery disease and in those with comor-
bidity. Functional outcome (Barthel Index) had slight statis-
tically significant effect on patients SF-36v2 mental health
score, shown by the non-parametric Spearman’s rank corre-
lation analysis.
Although there are few data in literature about HRQoL in
patients with severe carotid artery stenosis, several studies
have been conducted to evaluate the HRQoL in patients
with symptomatic carotid artery disease. In most cases,
studies have analysed HRQoL in patients with stroke, but
our study included both symptomatic patients with stroke or
TIA and asymptomatic patients with no history of stroke or
TIA. In our study, patients were enrolled with minor stroke
(maximal NIHSS score was 9 for only one patient and in
more than half of patients the Barthel Index was 20).
In the CREST trial (Carotid Revascularization Endarterec-
tomy versus Stenting Trial) mean SF-36 scores of patients
with symptomatic and asymptomatic significant carotid
stenosis were higher than in our study, except for role-
physical (46.4 ± 43.8) (Cohen et al., 2011). However, lower
rates of mean SF-36v2 scores of physical functioning, role-
physical, vitality reported in the SAPPHIRE trial (Stenting
and Angioplasty with Protection in Patients at High Risk for
Endarterectomy), compared with results from our study
(Stolker et al., 2010). The difference may be explained by
differences in patient groups, as patients in the SAPPHIRE
trial had greater burden of comorbidity. In another smaller
single centre study, SF-36 scores for physical functioning,
role-physical, bodily pain, general health, vitality were
higher than in our study, but role-emotional and mental
health scores were lower (Vlajinac et al., 2013). One of the
reasons for these differences might be the difference in dis-
ease severity of subjects and the number of included pa-
tients in the study. Another reason could be the difference in
length of time between the onset of disease and measure-
ment of HRQoL. Improvement in HRQoL with increasing
post-stroke time duration was reported in several studies
(Kong and Yang, 2006; Patel et al., 2006, Vlajinac et al.,
2013). There is a possibility that the SF-36 subscale scores
are dependent on time (Naess et al., 2006).
Although there were no statistically significant difference in
mean SF-36v2 score for women and men in our study, a
slight difference has been observed in other studies (Sturm,
2004; Almborg, 2009) and in general populations (Hopman
et al., 2004; Vlajinac et al., 2013). This might be because
women experience more mental impairment, depression and
fatigue after stroke, which is related to HRQoL (Naess et
al., 2006).
In our study BMI and comorbidity (other atherosclerotic
diseases, diabetes mellitus) had only slight effect on
HRQoL in patients with significant carotid stenosis, al-
though in other studies these parameters are more related to
T a b l e 3
NON-PARAMETRIC SPEARMAN’S RANK CORRELATION OF MEAN SF-36V2 SCORES IN PATIENTS WITH SEVERE CAROTID ARTERY STE-
NOSIS
PF RP BP GH VT SF RE MH
BMI rs 0.167 0.051 0.132 0.241 0.023 0.126 0.026 0.145
p 0.386 0.793 0.496 0.207 0.904 0.515 0.897 0.452
Barthel Index rs 0.313 0.221 0.006 0.217 0.158 0.235 0.245 0.383*
p 0.077 0.217 0.974 0.225 0.381 0.188 0.176 0.028
MoCA test rs 0.201 0.276 0.277 0.179 0.188 0.301 0.197 0.441*
p 0.263 0.120 0.11 9 0.318 0.295 0.088 0.279 0.010
BMI, body mass index; PF, physical functioning; RP, role participation with physical health problems (role-physical); BP, bodily pain; GH, general health;
VT, vitality; SF, social functioning; RE, role participation with emotional health problems (role-emotional); MH, mental health; rs (Spearman’s correlation
coefficient); p (significance of rs).
Fig. 1. Correlation between MoCA score and mean SF-36v2 score of men-
tal health domain.
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both carotid disease and HRQoL (Regensteiner et al., 2008;
Tziallas et al., 2012).
The literature to date provides some evidence that MoCA
covers the range of content that is required for the assess-
ment of cognitive impairment in cerebrovascular disease,
with the exception of mental processing speed (Koski,
2013). Several recent studies have shown significant im-
provement of cognitive function after either carotid artery
endarterectomy or stenting (Gaudet et al., 2009; Baracchini
et al., 2012; Yoon et al., 2015). Therefore we evaluated the
cognitive function with a brief screening MoCA test of pa-
tients with significant carotid artery stenosis in this part of
our study, with the aim to follow up these patients after
endovascular treatment.
This study had several limitations. The number of patients
was relatively small. We did not analyse data about the time
period between the occurrence of stroke and measurement
of HRQoL. There are no HRQoL data for the general popu-
lation of Latvia. We are continuing our study to assess the
effect of endovascular treatment on HRQoL and the cogni-
tive function in patients with severe carotid artery stenosis.
In conclusion, patients with severe carotid artery disease in
our study had lower mean SF-36v2 scores for role-physical,
for bodily pain and for perception about health status (gen-
eral health). HRQoL in patients with severe carotid artery
stenosis was poorer in patients with symptomatic carotid ar-
tery disease and was not affected by gender and other clini-
cal characteristics.
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AR VESELÎBU SAISTÎTÂS DZÎVES KVALITÂTES NOVÇRTÇJUMS PACIENTIEM AR NOZÎMÎGU MIEGA ARTÇRIJAS STENOZI
Dati par pacienta ar veselîbu saistîtâs dzîves kvalitâtes izmaiòâm pçc revaskularizâcijas, un par to, kâ veiktâ manipulâcija ietekmç pacienta
ikdienas aktivitâtes, kognitîvâs funkcijas un vispârçjo veselîbas stâvokli, un vai ðiem faktoriem varçtu bût nozîme pielietojamâs
revaskularizâcijas metodes izvçlç, pasaules literatûrâ ir diskutabli. Ðî pçtîjuma mçríis bija novçrtçt ar veselîbu saistîtâs dzîves kvalitâtes
izmaiòas pacientiem ar nozîmîgu miega artçrijas stenozi, tâpat arî ar veselîbu saistîtâs dzîves kvalitâtes atðíirîbas pacientiem ar
simptomâtisku un asimptomâtisku miega artçrijas stenozi; novçrtçt iespçjamu saistîbu starp dzîves kvalitâti un pacientu demogrâfiskiem un
klîniskiem parametriem. Pçtîjumâ tika iekïauti 33 pacienti. Dzîves kvalitâtes novçrtçjuma anketa (SF-36v2) vidçjâs zemâkâs fiziskâs
funkcionâlâs spçjas (PF) vçrtîbas bija pacientiem ar pârciestu cerebrâlu infarktu. SF-36v2 vçrtîbas, kas attiecas uz fiziskâ veselîbas stâvokïa
ietekmi uz iesaistîðanos darbâ un citâs ikdienas aktivitâtçs (RF) bija zemas pacientiem ar pârciestu cerebrâlu infarktu, kâ arî pacientiem ar
citâm blakus saslimðanâm. Sievietçm, pacientiem ar pârciestu cerebrâlu infarktu, kâ arî pacientiem ar citâm blakus saslimðanâm sâpju
sindroma izteiktîbas un ietekmes uz darbu un citâm ikdienas aktivitâtçm (BP) vçrtîbas bija zemâkas, bet kopçjâ veselîbas stâvokïa
paðvçrtçjuma (GH) zemâkâs vçrtîbas bija tikai sievietçm. Lai gan nebija statistiski ticamu atðíirîbu, tomçr SF-38v2 fiziskâs funkcionâlâs
spçjas (PF) vçrtîbas un vçrtîbas, kas attiecas uz fiziskâ veselîbas stâvokïa ietekmi uz iesaistîðanos darbâ un citâs ikdienas aktivitâtçs (RF),
varçtu mainîties, ja pçtîjumâ tiktu iekïauti vairâk pacientu, jo redzams, ka standartdeviâcija ir salîdzinoði liela. Pçtîjumâ tika novçrota
statistiski ticama vidçji cieða korelâcija starp vidçjâm SF-36v2 psihiskâs veselîbas vçrtîbâm un MoCA testa rezultâtiem. Tika netieði
novçrota iespçjama korelâcija starp MoCA testa vçrtîbâm un vidçjâm SF-36v2 fiziskâ un psihoemocionâlâ stâvokïa ietekmes uz sociâlajâm
aktivitâtçm (SF) vçrtîbâm, kas varçtu bût statistiski ticamas, ja pacientu skaits bûtu lielâks. Pacientiem ar nozîmîgu miega artçrijas stenozi
bija zemâkas vçrtîbas, kas attiecas uz fiziskâ veselîbas stâvokïa ietekmi uz iesaistîðanos darbâ un citâs ikdienas aktivitâtçs (RF), sâpju
sindroma izteiktîbu un ietekmi uz darbu un citâm ikdienas aktivitâtçm (BP) un kopçjâ veselîbas stâvokïa paðvçrtçjuma (GH) vçrtîbas. Ar
veselîbu saistîtâs dzîves kvalitâte bija zemâka pacientiem ar iepriekð pârciestu cerebrâlu infarktu, un to neietekmçja ne dzimums, ne citi
klîniskie parametri.
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